Loading...
Updated Evaluation of the Safety, Efficacy and Tolerability of Pirfenidone in the Treatment of Idiopathic Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis (IPF) is a chronic fibrotic disease characterized by a progressive decline in lung function with a median survival of 3–5 years after diagnosis. The course of disease is highly variable and unpredictable, often punctuated by episodes of acute respiratory failure, known...
Na minha lista:
| Udgivet i: | Drug Healthc Patient Saf |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7213901/ https://ncbi.nlm.nih.gov/pubmed/32440226 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DHPS.S224007 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|